The Danish company is citing a steep decline in the company’s share price.
Subscribe to continue reading this article.
Already subscribed? To log in, click here.
Originally Published:
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
At the peak, the company's market capitalization exceeded Denmark's annual gross domestic product and made it Europe's most valuable company
